Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2,Condition 3,Condition 4 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.2,mmol/l,2.1,5.1439,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102242,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.7,mmol/l,2.2,5.3889,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102244,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood molecular composition trait,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0002923,plasma osmolality,,p osmolality mosm/kg,,301.8,umol/g,3.8,9.3081,MMO:0000170,osmometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102246,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood molecular composition trait,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0002923,plasma osmolality,,,,301.3,umol/g,4.3,10.5328,MMO:0000170,osmometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),102248,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days), 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,141.1,mmol/l,1.8,4.4091,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102254,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood sodium amount,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0000060,plasma sodium level,,,,140.4,mmol/l,1.1,2.6944,MMO:0000039,flame atomic emission spectrometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102256,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood molecular composition trait,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0002923,plasma osmolality,,p osmolality mosm/kg,,301.8,umol/g,3.6,8.8182,MMO:0000170,osmometry,,0.0,,,,,controlled sodium content diet (0.4 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102262,controlled sodium content diet (0.4 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days) 2682,"Wainford RD, et al., Hypertension. 2015 Jan;65(1):178-86. doi: 10.1161/HYPERTENSIONAHA.114.04463. Epub 2014 Oct 13.",blood molecular composition trait,,RS:0000922,SS/Hsd,male,119 days to 91 days,6,,CMO:0002923,plasma osmolality,,p osmolality mosm/kg,,301.2,umol/g,3.2,7.8384,MMO:0000170,osmometry,,0.0,,,,,controlled sodium content diet (8 %) (for 21 days) then intracerebroventricular cannula implantation then Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days) then surgical denervation (for 21 days),102264,controlled sodium content diet (8 %) (for 21 days),intracerebroventricular cannula implantation,Gnai2 antisense oligonucleotide (4.17 ug/d) (for 21 days),surgical denervation (for 21 days)